Iveric Bio Stock Current Valuation
Valuation analysis of IVERIC Bio helps investors to measure IVERIC Bio's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
IVERIC Bio Company Current Valuation Analysis
IVERIC Bio's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current IVERIC Bio Current Valuation | 4.98 B |
Most of IVERIC Bio's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IVERIC Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, IVERIC Bio has a Current Valuation of 4.98 B. This is 65.32% lower than that of the Biotechnology sector and 7.24% higher than that of the Health Care industry. The current valuation for all United States stocks is 70.03% higher than that of the company.
IVERIC Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IVERIC Bio's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of IVERIC Bio could also be used in its relative valuation, which is a method of valuing IVERIC Bio by comparing valuation metrics of similar companies.IVERIC Bio is currently under evaluation in current valuation category among its peers.
IVERIC Fundamentals
| Return On Equity | -0.55 | |||
| Return On Asset | -0.3 | |||
| Current Valuation | 4.98 B | |||
| Shares Outstanding | 137.98 M | |||
| Shares Owned By Insiders | 0.65 % | |||
| Shares Owned By Institutions | 99.35 % | |||
| Number Of Shares Shorted | 16.64 M | |||
| Price To Earning | 4.17 X | |||
| Price To Book | 3.81 X | |||
| Gross Profit | (117.01 M) | |||
| EBITDA | (192.28 M) | |||
| Net Income | (185.21 M) | |||
| Cash And Equivalents | 311.96 M | |||
| Cash Per Share | 2.64 X | |||
| Total Debt | 97.77 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 11.98 X | |||
| Book Value Per Share | 3.48 X | |||
| Cash Flow From Operations | (163.77 M) | |||
| Short Ratio | 5.25 X | |||
| Earnings Per Share | (1.82) X | |||
| Target Price | 39.1 | |||
| Number Of Employees | 163 | |||
| Beta | 1.1 | |||
| Market Capitalization | 5.51 B | |||
| Total Asset | 666.82 M | |||
| Retained Earnings | (864.81 M) | |||
| Working Capital | 627.24 M | |||
| Current Asset | 121.07 M | |||
| Current Liabilities | 14.54 M | |||
| Z Score | 32.19 | |||
| Net Asset | 666.82 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in IVERIC Stock
If you are still planning to invest in IVERIC Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IVERIC Bio's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |